HEALTH / PHARMA

Govt. of India bestows Transasia with ‘India Medical Devices Export Company of the Year’ award 

by Suman Gupta 

Bangalore,  February, 2018: Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, announced today that it has been conferred the ‘India Medical Devices Export Company of the Year’ award by the Ministry of Chemicals & Fertilizers, Government of India.

Mr. Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd. received the award through the hands of Shri Ananth Kumar, Hon’ble Minister (Chemicals & Fertilizers), Government of India, at the 3rd International Exhibition & Conference on Pharmaceutical & Medical Devices Industry – India Pharma 2018 & India Medical Device 2018 held today at the Bangalore International Exhibition Centre, Bengaluru. Shri Suresh Prabhu, Union Minister of Commerce and Industry, Shri Jagat Prakash Nadda, Hon’ble Union Minister for Health & Family Welfare and other well known dignitaries graced the conference.

On receiving the award, Mr. Vazirani remarked, “I am honored to receive this prestigious award and grateful to the Ministry of Chemicals & Fertilizers, Government of India for conferring it on us. I am proud that Transasia is contributing to the growth of the economy through its exports to over 110 countries. With a vision of creating a ‘Healthier and Happier World’, Transasia has been successfully combining world-class technologies from our global subsidiaries with efficient, low cost manufacturing in India to meet the diagnostic needs of India and the other emerging markets.”

He further added, “On this note, I would like to thank the Government of India for recognizing medtech as a sunrise sector in its Make in India initiative. India’s products are being recognized worldwide for their quality, reliability and affordability. The recent reforms are giving an impetus to the growth of this sector. Further boosts are welcome.”

The award for the ‘India Medical Devices Export Company of the year’ category along with other categories was instituted by the Govt. of India in order to encourage indigenous manufacturing of medical devices.

To this effect, Transasia is the first Indian In-vitro Diagnostic Company to manufacture and export state-of-the-art blood analyzers and reagents, way back in 1990s. Transasia’s main focus remains on the emerging countries in Asia, Africa, the Middle East, Latin America and Eastern Europe. In Asia, besides India it caters to the diagnostic needs of countries such as Thailand, Indonesia, Philippines and Vietnam. With over 14 overseas acquisitions in countries as varied as the Czech Republic, Germany, U.K, France, Italy, Russia, Turkey, and the US, Transasia serves millions.

The exhibition brought together key decision makers from the realms of the industry, academia, regulators and government to gauge opportunities and estimate the potential of indigenous manufacturing for medical devices in India and thereby create an ecosystem to enable path breaking initiatives and innovations.

About Transasia Bio-Medicals Ltd.  : Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment in 35,000 laboratories across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 21 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘Global Growth Company-2014’ by the World Economic Forum amongst many others.Headquartered in Mumbai, Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba –Transasia Group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions.Erba’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables.Today, the Erba -Transasia Group serves millions across 110 countries.

Related posts

Nation completes one year of COVID19 vaccination; Over 157 crore Covid Vaccination doses administered so far in the country

ALLERGIES AND STRONG GUSTS OF WIND CAN TRIGGER THUNDERSTORM ASTHMA

Covid vaccines are safe and effective – why the hesitancy?

Leave a Comment

+ 76 = 81